Image Analysis CRO: Advanced preclinical imaging solutions

At Imavita, we develop cutting-edge image analysis services as a CRO (Contract Research Organization) partner. Image analysis and imaging biomarker quantification enables pharmaceutical, biotechnology, and academic customers to obtain precise, reliable, and actionable data for drug development and research. We implemented a specific department equipped with advanced softwares and tools.

Image analysis in preclinical research

Image analysis is a critical step in extracting quantitative and qualitative insights from imaging data generated during preclinical studies. It helps researchers evaluate treatment efficacy, understand disease progression, and support decision-making with detailed imaging biomarkers.

Our image analysis services

As an expert image analysis CRO, we offer tailored solutions to meet the specific needs of preclinical studies with the following services:

Quantitative
analysis

Extraction of precise numerical data to assess, for example tumor volumes, tissue density, or signal intensity changes over time.

Qualitative
interpretation

Advanced visualization techniques to better understand treatment effects and disease mechanisms or drugs pharmacokinetics.

Multimodal image integration

Combining imaging modalities such as optical imaging BLI, FRI, OCT, MRI, PET/CT, for comprehensive insights.

Biomarker discovery

Identification and validation of imaging biomarkers for drug efficacy, or disease characterization.

Customized reporting

Delivery of detailed, publication-ready reports with high-resolution images and statistical analyses.

Quantitative
analysis

Extraction of precise numerical data to assess, for example tumor volumes, tissue density, or signal intensity changes over time.

Qualitative
interpretation

Advanced visualization techniques to better understand treatment effects and disease mechanisms or drugs pharmacokinetics.

Multimodal image integration

Combining imaging modalities such as optical imaging BLI, FRI, OCT, MRI, PET/CT, for comprehensive insights.

Biomarker discovery

Identification and validation of imaging biomarkers for drug efficacy, or disease characterization.

Customized reporting

Delivery of detailed, publication-ready reports with high-resolution images and statistical analyses.

Our advanced tools and collaborations for the quantification of imaging biomarkers and image analysis

Tools

In vivo imaging: Imalytics®, 3DSlicer®, Osirix® with in house developed plugins.
SPECT / CT / ultrasonography embedded softwares.
OCT proprietary segmentation tools.
QuPath, FiJi, napari based tools.
Targeted open or proprietary tools.

Resources & Collaborations

Collaborations with public and private labs (satellite imaging and specific image treatment).

Applications of our Image analysis CRO services

Our image analysis solutions support a wide range of preclinical research applications, including:

Dermatology

Oncology

Neurology

Osteo-articular

Cardiovascular

Infectious diseases

Study of drug disposition and pharmacokinetics (PK)

Dermatology

Oncology

Neurology

Osteo-articular

Cardiovascular

Infectious diseases

Study of drug disposition and pharmacokinetics (PK)

The benefits of working with Imavita in image analysis

Expertise in imaging

With years of experience in preclinical imaging, our team has supported numerous drug development projects across dermatology, osteo-articular and oncology.

Advanced technology

We utilize cutting-edge imaging platforms and analysis software to provide accurate, high-quality results.

Tailored solutions

Our skilled scientists are available to help you select endpoint-specific solutions and assist in designing studies and protocols.

Data integrity and compliance

Our workflows adhere to industry standards, ensuring data reliability and reproducibility.

Contact Imavita for reliable image analysis CRO services